Intratumoral injection of AMF/PGI-paclitaxel induced tumor regression and increased survival of tumor bearing mice, identifying AMF/PGI-paclitaxel as a potential targeted therapeutic agent for gp78/AMFR-positive cancers. The gene discussed is AMFR; the disease is neoplasm.